Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Hoth Therapeutics Approved To Proceed With First-In-Human Phase 2a Clinical Trial Of HT-001 For Treatment Of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors

Author: Benzinga Newsdesk | July 16, 2024 08:34am

Three New Sites Join HT-001 Trial, GW University Hospital, UC Irvine and Northwell Health

Posted In: HOTH